Vivus, Inc.
Records under this name other than the patents Vivus, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,841,300 | Treatment for Parkinson's disease—combination high dose serotonergic synaptic reuptake inhibitor with phosphodiesterase inhibitor Formerly held Lapsed on the fee record Ended Sep 23, 2022 · From the USPTO record | Lapsed on the fee record | Ended Sep 23, 2022 | From the USPTO record |
| US 7,674,776 | Combination Therapy for Effecting Weight Loss and Treating Obesity Lapsed on the fee record Ended Mar 9, 2022 · Medium confidence | Lapsed on the fee record | Ended Mar 9, 2022 | Medium confidence |
| US 7,659,256 | Combination Therapy for Effecting Weight Loss and Treating Obesity Lapsed on the fee record Ended Feb 9, 2022 · Medium confidence | Lapsed on the fee record | Ended Feb 9, 2022 | Medium confidence |
| US 7,553,818 | Combination Therapy for Effecting Weight Loss and Treating Obesity Lapsed on the fee record Ended Jun 30, 2021 · Medium confidence | Lapsed on the fee record | Ended Jun 30, 2021 | Medium confidence |
| US 8,440,671 | Compositions comprising a phoshodiesterase-5 inhibitor and their use in methods of treatment Formerly held Lapsed on the fee record Ended May 14, 2021 · From the USPTO record | Lapsed on the fee record | Ended May 14, 2021 | From the USPTO record |
| US 6,946,141 | As-needed administration of tricyclic and other non-SRI antidepressant drugs to treat premature ejaculation Term ended Term ended Feb 21, 2021 · From the USPTO record | Term ended | Term ended Feb 21, 2021 | From the USPTO record |
| US 6,495,154 | On demand administration of clomipramine and salts thereof to treat premature ejaculation Term ended Term ended Dec 26, 2020 · From the USPTO record | Term ended | Term ended Dec 26, 2020 | From the USPTO record |
| US 7,056,890 | Combination Therapy for Effecting Weight Loss and Treating Obesity Term ended Term ended Jun 14, 2020 · Medium confidence | Term ended | Term ended Jun 14, 2020 | Medium confidence |
| US 8,802,636 | Combination Therapy for Treatment of Sleep Apnea Term ended Term ended Jun 14, 2020 · Medium confidence | Term ended | Term ended Jun 14, 2020 | Medium confidence |
| US 9,011,905 | Low Dose Topiramate/Phentermine Composition and Methods of Use Thereof Term ended Term ended Jun 14, 2020 · Medium confidence | Term ended | Term ended Jun 14, 2020 | Medium confidence |